American Society of Breast Disease Statement on Digital Breast Tomosynthesis
American Society of Breast Disease (ASBD) Statement on Digital Breast Tomosynthesis
From the ASBD statement: The potential benefits of DBT include a reduction in the tissue overlap leading to increase sensitivity and specificity of breast cancer detection. It may also improve the characterizations of different lesion types. Early clinical studies suggest that DBT reduces screening recall rates, improves screening sensitivity and improves diagnostic accuracy [4-13]. DBT does not have its own CPT code. In addition, solutions for workflow issues regarding the display and storage of these images continues to evolve in a positive direction.
Read more here.
The Mission of the ASBD:
To advance the multidisciplinary team approach to breast healthcare through professional education, consensus development and training programs.